Lv6
3070 积分 2024-03-07 加入
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
16天前
已完结
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
16天前
已完结
The Evolving Landscape of Antibody–Drug Conjugates: In Depth Analysis of Recent Research Progress
21天前
已完结
The Evolving Landscape of Antibody–Drug Conjugates: In Depth Analysis of Recent Research Progress
21天前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
21天前
已完结
Antibody-drug conjugates: Current challenges and innovative solutions for precision cancer therapy
21天前
已完结
Mechanism of Protein–PDMS Visible Particles Formation in Liquid Vial Monoclonal Antibody Formulation
23天前
已完结
Efficacy and Safety of Iparomlimab, an Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors: A Phase 1c Study
29天前
已完结
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis
2个月前
已完结
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis
2个月前
已完结
皖公网安备34019202002308
